Overview

A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
Many patients with type 2 diabetes also have conditions that are treated with diuretics. The patients may also be treated with GSK189075 for their diabetes. This study is planned to assess possible effects of administering GSK189075 in combination with two frequently used diuretics.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Furosemide
Hydrochlorothiazide
Remogliflozin etabonate